Key result
Medication compliance and disease understanding predict 30-day survival with symptom improvement in acute CVD.
Why the study?
Little is known about healthcare-seeking behaviour and barriers to care for cardiovascular disease in sub-Saharan Africa.
Cohort (n=241)
Answers are grounded in this paper and cite their sources.
In Tanzania, patients with acute CVD often experience delayed care and poor understanding of their condition, which correlates with worse 30-day survival and symptom improvement.
Background Little is known about healthcare-seeking behaviour and barriers to care for cardiovascular disease (CVD) in sub-Saharan Africa. Methods Emergency department patients in Tanzania with acute CVD were prospectively enrolled. Questionnaires were administered at enrollment and 30 d later. Results Of 241 patients, 186 (77.2%) had visited another facility for the same illness episode (median symptom duration prior to presentation was 7 d) and 82 (34.0%) reported that they were initially unaware of the potential seriousness of their symptoms. Of the 208 (86.3%) patients completing follow-up, 16 (7.7%) had died, 38 (18.3%) had visited another facility for persistent symptoms, 99 (47.6%) felt they understood their diagnosis, 87 (41.8%) felt they understood their treatment and 11 (7.8%) could identify any of their medications. Predictors of 30 d survival with symptom improvement included medication compliance (p<0.001), understanding the diagnosis (p=0.007), understanding the treatment (p<0.001) and greater CVD knowledge (p=0.008). Conclusions Patients with CVD in Tanzania usually visit multiple facilities for the same illness episode, typically after prolonged delays. Only a minority understand their diagnosis and treatment, and such understanding is correlated with survival with symptom improvement. Patient-centred interventions are needed to improve the quality of cardiovascular care in Tanzania.
No takes yet. Share an insight, caveat, or question.
Hertz et al. (2019) conducted a cohort in acute cardiovascular disease (n=241). Medication compliance (p<0.001), understanding the diagnosis (p=0.007), and understanding the treatment (p<0.001) were significant predictors of 30-day survival with symptom improvement in acute CVD.
Synapse has enriched 10 related papers. Consider them for comparative context: